Lazard Asset Management’s Organogenesis Holdings ORGO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-649,384
| Closed | -$2.81M | – | 2468 |
|
|
2025
Q1 | $2.81M | Buy |
649,384
+477,690
| +278% | +$2.06M | ﹤0.01% | 863 |
|
|
2024
Q4 | $549K | Buy |
171,694
+94,514
| +122% | +$302K | ﹤0.01% | 1336 |
|
|
2024
Q3 | $220K | Buy |
77,180
+26,361
| +52% | +$75.1K | ﹤0.01% | 1586 |
|
|
2024
Q2 | $142K | Buy |
50,819
+28,028
| +123% | +$78.3K | ﹤0.01% | 1654 |
|
|
2024
Q1 | $64K | Sell |
22,791
-1,689
| -7% | -$4.74K | ﹤0.01% | 1670 |
|
|
2023
Q4 | $100K | Buy |
24,480
+1,561
| +7% | +$6.38K | ﹤0.01% | 1655 |
|
|
2023
Q3 | $72K | Hold |
22,919
| – | – | ﹤0.01% | 1749 |
|
|
2023
Q2 | $76K | Hold |
22,919
| – | – | ﹤0.01% | 1684 |
|
|
2023
Q1 | $48K | Buy |
22,919
+9,520
| +71% | +$19.9K | ﹤0.01% | 1816 |
|
|
2022
Q4 | $36K | Sell |
13,399
-14,695
| -52% | -$39.5K | ﹤0.01% | 1947 |
|
|
2022
Q3 | $91K | Buy |
28,094
+13,166
| +88% | +$42.6K | ﹤0.01% | 1506 |
|
|
2022
Q2 | $72K | Buy |
14,928
+5,822
| +64% | +$28.1K | ﹤0.01% | 1649 |
|
|
2022
Q1 | $69K | Buy |
9,106
+8,873
| +3,808% | +$67.2K | ﹤0.01% | 1573 |
|
|
2021
Q4 | $2K | Sell |
233
-919
| -80% | -$7.89K | ﹤0.01% | 2223 |
|
|
2021
Q3 | $16K | Sell |
1,152
-6,505
| -85% | -$90.3K | ﹤0.01% | 2044 |
|
|
2021
Q2 | $127K | Sell |
7,657
-2,183
| -22% | -$36.2K | ﹤0.01% | 1291 |
|
|
2021
Q1 | $179K | Hold |
9,840
| – | – | ﹤0.01% | 1116 |
|
|
2020
Q4 | $74K | Buy |
9,840
+8,688
| +754% | +$65.3K | ﹤0.01% | 1266 |
|
|
2020
Q3 | $4K | Buy |
+1,152
| New | +$4K | ﹤0.01% | 1553 |
|